HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bennett P deBoisblanc Selected Research

Septic Shock (Toxic Shock Syndrome)

10/2018Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.
12/2016It Is About Time: Antibiotic Delays in the Treatment of Septic Shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bennett P deBoisblanc Research Topics

Disease

6Critical Illness (Critically Ill)
11/2019 - 12/2010
3Pulmonary Hypertension
01/2022 - 01/2019
3Inflammation (Inflammations)
04/2021 - 01/2016
2Chronic Obstructive Pulmonary Disease (COPD)
04/2021 - 01/2016
2Pulmonary Arterial Hypertension
01/2019 - 07/2017
2Sepsis (Septicemia)
10/2018 - 06/2014
2Septic Shock (Toxic Shock Syndrome)
10/2018 - 12/2016
2Acute Lung Injury
10/2011 - 02/2002
2Lung Injury
03/2005 - 02/2002
1Systemic Scleroderma (Systemic Sclerosis)
01/2019
1Edema (Dropsy)
10/2018
1Pneumonia (Pneumonitis)
03/2016
1Hepatitis
03/2016
1Human Influenza (Influenza)
03/2016
1Respiratory Hypersensitivity
01/2016
1Shock
10/2015
1Liver Failure
06/2014
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2014
1Renal Insufficiency (Renal Failure)
06/2014
1Fever (Fevers)
01/2014
1Hyperthermia
01/2014
1Respiratory Insufficiency (Respiratory Failure)
12/2010
1Hemorrhage
03/2005
1Hypertension (High Blood Pressure)
10/2002
1Connective Tissue Diseases (Connective Tissue Disease)
10/2002
1Hypotension (Low Blood Pressure)
10/2002

Drug/Important Bio-Agent (IBA)

2Iloprost (Ventavis)FDA Link
04/2021 - 01/2016
2Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2021 - 01/2016
2Anti-Bacterial Agents (Antibiotics)IBA
12/2016 - 01/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2019
1Oxygen (Dioxygen)IBA
10/2018
1macitentanIBA
07/2017
1Pharmaceutical PreparationsIBA
07/2017
1Thiamine (Aneurin)FDA Link
03/2016
1ProstaglandinsIBA
01/2016
1Pancreatic Elastase (Elastase)IBA
01/2016
1Crystalloid SolutionsIBA
10/2015
1AlbuminsIBA
10/2015
1GhrelinIBA
10/2015
1Rosuvastatin Calcium (Crestor)FDA Link
06/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2014
1PyrogensIBA
01/2014
1Eicosapentaenoic AcidIBA
10/2011
1Fatty Acids (Saturated Fatty Acids)IBA
10/2011
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
10/2011
1Docosahexaenoic AcidsIBA
10/2011
1alpha-Linolenic Acid (Linolenic Acid)IBA
10/2011
1gamma-Linolenic AcidIBA
10/2011
1AntioxidantsIBA
10/2011
1AdiponectinIBA
12/2010
1CytokinesIBA
12/2010
1Endothelin-1 (Endothelin 1)IBA
03/2005
1AcidsIBA
03/2005
1Hydrochloric Acid (Hydrogen Chloride)FDA Link
03/2005
1Vasodilator Agents (Vasodilators)IBA
10/2002
1DiureticsIBA
10/2002
1Oleic Acid (Oleate)IBA
02/2002
1DobutamineFDA LinkGeneric
02/2002

Therapy/Procedure

4Therapeutics
01/2016 - 02/2002
1Device Removal (Removal, Device)
11/2019
1Fluid Therapy (Oral Rehydration Therapy)
10/2018
1Resuscitation
10/2018
1Catheters
10/2015
1Artificial Respiration (Mechanical Ventilation)
10/2011
1Enteral Nutrition (Feeding, Tube)
10/2011
1Mechanical Ventilators (Ventilator)
10/2011
1Positive-Pressure Respiration (Positive End-Expiratory Pressure)
03/2005
1Renal Replacement Therapy (Therapies, Renal Replacement)
10/2002